Page results
-
This page has been written for patients who are having radiotherapy to the breast or chest wall area.
-
The Neuroimmunology and CSF Laboratory at the Institute of Neurology, UCLH is a UKAS accredited medical laboratory No. 8045.
-
This page is for parents, carers and relatives whose child is having radiotherapy treatment to the eye (orbit). There are different conditions that may require radiotherapy to the eye such as retinoblastoma, orbital rhabdomyosarcomas, soft tissue sarcomas, lymphomas, or some other condition.
-
CAR T-cell therapy is a cutting-edge treatment for certain blood cancers, offering new hope to patients whose illness hasn’t responded to standard treatments. University College London Hospitals (UCLH) is proud to be one of Europe’s leading centres for this advanced care.
-
Acute loss of sense of smell should be considered globally as a criterion for self-isolation, testing, and contact tracing for Covid-19 infection according to researchers at UCLH and UCL.
-
This page explains what autologous stem cell transplant is and includes information about our stem cell transplant service and process, the care patients will receive and what to expect after the transplant.
-
This page is intended for patients who suffer from laryngeal dystonia (formerly known as spasmodic dysphonia) who might benefit from this therapy.
-
This page is designed for patients scheduled to attend the Adult diagnostic audiology department. It outlines the various tests that may be conducted during your appointment.
-
For people with autoimmune conditions, including multiple sclerosis (MS) and scleroderma: Collecting stem cells from your blood
-
This page has been written for patients who are receiving proton beam therapy (PBT) to the prostate.
File results
-
FOI/2023/0515 - Visitor policy in response to Covid-19
-
FOI/2023/0513 - Radiology equipment inventory
-
FOI/2023/0497 - List of all laboratories within Pathology
-
FOI/2023/0486 - Mastectomy reconstruction
-
FOI/2023/0484 - Babies diagnosed with Tongue Tie
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0305 - Trust held non-pharmaceutical consignment stock holding
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2023/0303 - Sexual harassment from patients towards staff in 2022
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine